SEC Contract Filing

Filing Date: 2022-08-04

Document Content:
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>cue-ex10_2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html>
 <head>
 <title>EX-10.2</title>
 </head>
 <body>
 <p style="margin-left:60.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"></font>&#160;</p>
 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 10_2</font></p>
 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </font>&#160;</p>
 <p style="margin-left:31.507%;text-indent:0.0%;font-size:10.0pt;margin-top:4.05pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:33.176%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;">Rider to License Agreement Vivarium</font></p>
 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.5pt;font-family:Times New Roman;min-width:fit-content;"></font>&#160;</p>
 <p style="margin-left:1.48%;text-indent:6.987%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:3.111%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(72,72,74,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;">This Rider to License Agreement (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(72,72,74,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;">Rider</font><font style="background-color:rgba(0,0,0,0);color:rgba(72,72,74,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), is made as of July 7, 2022, by and between MIL 40G, LLC (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(72,72,74,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;">SmartLabs</font><font style="background-color:rgba(0,0,0,0);color:rgba(72,72,74,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), and Cue Biopharma, Inc. (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(72,72,74,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;">Licensee</font><font style="background-color:rgba(0,0,0,0);color:rgba(72,72,74,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></p>
 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"></font>&#160;</p>
 <p style="margin-left:1.48%;text-indent:6.983%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:3.056%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;">WHEREAS, SmartLabs and Licensee are parties to that certain License Agreement, as amended, dated March 28, 2022 (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;">License Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). All capitalized terms used herein without definition shall have the meanings ascribed to them in the License Agreement. This Rider shall be governed by the terms of the License Agreement and if there is any conflict between the covenants and representations contained in the License Agreement and the Rider, the terms of the License Agreement shall prevail and be binding upon Licensor and Licensee;</font></p>
 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"></font>&#160;</p>
 <p style="margin-left:1.48%;text-indent:6.983%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:3.046%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;">WHEREAS, all terms and conditions applied to, and all obligations imposed against, Licensee with respect to the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;">License</font><font style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-